Evidence map›Paper›PMID 38927449›Full record

ArticleBiomedicines2024

An Unusual Presentation of Synchronous Breast Cancer and Skin Malignancy in a Patient with Lynch Syndrome: A Case Report and Review of the Literature.

Maiar Elghobashy, Michael Siafakas, Mona Elshafie, Rahul Hejmadi, Naren N Basu, Abeer M Shaaban

Abstract readCase Reports
In one paragraph

Article in Biomedicines, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Maiar ElghobashyThe Royal Wolverhampton NHS Trust, Wolverhampton WV10 0QP, UK.ORCID 0000-0003-3271-7404
Michael SiafakasSouth Birmingham Screening, Queen Elizabeth Hospital Birmingham, Birmingham B15 2GW, UK.
Mona ElshafieCellular Pathology, Queen Elizabeth Hospital Birmingham, Birmingham B15 2GW, UK.
Rahul HejmadiCellular Pathology, Queen Elizabeth Hospital Birmingham, Birmingham B15 2GW, UK.
Naren N BasuOncoplastic Breast Surgery, Queen Elizabeth Hospital Birmingham, Birmingham B15 2GW, UK.
Abeer M ShaabanCellular Pathology, Queen Elizabeth Hospital Birmingham, Birmingham B15 2GW, UK.ORCID 0000-0001-5784-8705

Funding

A.M.S. was funded by Birmingham CR-UK Centre grant No. C17422/A25154. C17422/A25154
6 · The paper itself

Abstract

backgroundLynch syndrome is an autosomal dominant condition that leads to an increased risk of many neoplasms. In the United Kingdom, NICE recommends that patients with colorectal and endometrial cancer should be tested for Lynch syndrome. There is conflicting evidence in the literature on the link between breast cancer and Lynch syndrome. CASE PRESENTATION: A 54-year-old woman presented with a lump in her right breast with a background of locally advanced colorectal cancer and Lynch syndrome due to a MLH1 gene mutation. A core biopsy showed a grade 3, invasive, triple-negative NST carcinoma. The tumour was triple-negative with patchy positivity for CK14 and CK5/6. Simultaneously, a cystic skin lesion in the contralateral breast was noted, which comprised lesional cells with a proliferation of clear cells and bland basaloid cells. The lesion had evidence of sebaceous differentiation with AR, podoplanin and p63 positivity. MSH1 and PMS2 deficiency was found in the breast and skin lesions.

conclusionsIn Lynch syndrome, it is vital to be aware of the increased risk of various types of cancer. This case adds to the body of evidence of the spectrum of malignancies that can be encountered in patients with Lynch syndrome.

Indexed as

breast cancerLynch syndromesebaceous carcinomaskin cancer

Identifiers

PMID38927449
PMCPMC11201021

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.